Skip to main content
EJNMMI Radiopharmacy and Chemistry
Fig. 4 | EJNMMI Radiopharmacy and Chemistry

Fig. 4

From: Evaluation of the pharmacokinetics, dosimetry, and therapeutic efficacy for the α-particle-emitting transarterial radioembolization (αTARE) agent [225Ac]Ac-DOTA-TDA-Lipiodol® against hepatic tumors

Fig. 4

iQID-camera images and surface plots of tumors after administration of [225Ac]Ac-DOTA-TDA-Lipiodol® in tumor-bearing female and male mice at A 24-h, and B 144-h. The scale shows the activity (mBq) present in each sample (The scale was limited to 0–1.0 mBq, higher activities are present in the high activity areas as shown in the bottom row surface plots). The bottom row shows the 3D surface plots for the corresponding iQID-camera image of the tumors with x- and y-axis in length (mm) and the z-axis in units of activity 0–12.0 mBq

Back to article page